Explain this page
Arphra AIPlain-English read on Acumen Pharmaceuticals, Inc.’s valuation06-16today
- Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer's Disease3d
- Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer's Disease3d
- Acumen Pharmaceuticals, Inc. (ABOS) Q1 2026 Earnings Call Transcript37d
- Acumen Pharmaceuticals Q1 Earnings Call Highlights37d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $7.00 (+209.73%)
Candlestick · 1Y
Open in chart workstation →ABOS
2.34-9.65%H 3.60L 2.08MA50 2.64MA200 —Avg vol 518K
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.44% | -4.24% | +4.15% | -22.60% | +5.12% | +7.11% | +88.33% | -62.02% | -88.76% | -88.76% | -88.76% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$2.26
19 sh
Bid
$2.18
50 sh
Ask
$2.45
8 sh
Spread
$0.270
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Technology+2.51%
- Communication Services+1.85%
- Utilities+1.35%
- Consumer Cyclical+0.30%
- Consumer Defensive-0.30%
- Energy-0.45%
- Industrials-0.48%
- Basic Materials-0.66%
- Financial Services-0.67%
- Real Estate-0.99%
- Healthcare-1.51%
Top industries (issuer's industry highlighted)
- Biotechnology+0.28%
- Oil & Gas Energy+8.53%
- Business Equipment & Supplies+5.82%
- Semiconductors+5.24%
- Electronic Gaming & Multimedia+5.23%
- Advertising Agencies-5.20%
- Medical - Equipment & Services+5.08%
- Grocery Stores-4.35%
- Financial - Mortgages+4.08%
- Broadcasting+4.00%
- Computer Hardware-3.67%
- Internet Content & Information+3.58%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer's Diseaseglobenewswire.com·Jun 16, 2026
- Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer's Diseaseglobenewswire.com·Jun 16, 2026
- Acumen Pharmaceuticals, Inc. (ABOS) Q1 2026 Earnings Call Transcriptseekingalpha.com·May 12, 2026
- Acumen Pharmaceuticals Q1 Earnings Call Highlightsmarketbeat.com·May 12, 2026
- Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlightsglobenewswire.com·May 12, 2026
- Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlightsglobenewswire.com·May 12, 2026
- Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conferenceglobenewswire.com·May 07, 2026
- Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026globenewswire.com·May 05, 2026
Peers
No peer list available for ABOS.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|